Lafarge Malayan Cement Bhd (3794)
Bursa Malaysia · Malaysia · prices in MYR · close of 27 Oct 2026
Key indicators
| Last close | MYR 5.180 |
|---|---|
| 52-week range | 5.050 – 8.740 |
| Return, 1 month / 3 months | −6.2% / −17.5% |
| Return, 1 year / 3 years | −17.1% / +55.6% |
| Trend | Below its 200-day average |
| RSI (14) | 34 |
| Volatility (1 year) | 39.6% |
| Worst drawdown (1 year) | -39.4% |
| Average daily value traded | 7.20M MYR |
| Dividend yield | 2.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Lafarge Malayan Cement is a Malaysian producer of cement and building materials. The company makes cement and clinker at plants in the country and supplies these products to construction companies, contractors and distributors for use in buildings, infrastructure and other projects. Its operations are based in Malaysia, where it serves the domestic construction market with bulk and bagged cement and related materials.
On this site Lafarge Malayan Cement Bhd appears as a stock on the Bursa Malaysia (Malaysia), code 3794, with prices in Malaysian ringgit (MYR). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Lafarge Malayan Cement Bhd (3794) trades on the Bursa Malaysia in Malaysia. It last closed at MYR 5.180 on 27 October 2026.
Its price-based Market X-Ray is 37 out of 100 (a weak price profile), ranking 758 of 1,066 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 17.1% and over the last three months it fell 17.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Bursa Malaysia
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 13 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -21.9% | ||
| From 52-week high | -40.4% | ||
| Momentum | 23 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -17.5% | ||
| 6-month return | -23.8% | ||
| 12-month return, skipping the last month | -11.6% | ||
| Stability (higher is calmer) | 43 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 39.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -39.4% | ||
| Liquidity | 92 · Strong | Trades actively. | |
| Average daily value traded | 7.20M MYR | ||
| Zero-volume days | 1.7% | ||
| Income | 36 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.9% | ||
| Years with dividends | 4 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | −0.4% |
|---|---|
| 1 month | −6.2% |
| 3 months | −17.5% |
| 6 months | −23.8% |
| 1 year | −17.1% |
| 3 years | +55.6% |
| 5 years | +88.4% |
Signals
| 50-day / 200-day average | 5.673 / 6.633 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.143 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 10 Sep 2026 | MYR 0.0900 |
| 13 Mar 2026 | MYR 0.0600 |
| 11 Sep 2025 | MYR 0.0700 |
| 5 Mar 2025 | MYR 0.0500 |
| 29 Oct 2024 | MYR 0.0600 |
| 10 Jun 2024 | MYR 0.0400 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Bursa Malaysia; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.